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20 miRNAs in complex showed that decreased expression was
observed much less frequently in the samples with a later RCC
stage than in samples with early RCC stage. For example, in a
tumor sample of a patient with stage IV (T3aN2M1) expression
was reduced only for miR-129 and miR-375 in 10 times for each
miRNA, while the expression of miR-9 was increased. In samples
with stage III expression was reduced in 2 or 4 out of the selected
20 miRNAs, in samples with stage I expression decrease was
observed for 9 out of 20 studied miRNAs. Since kidney tissue from
the same patient was taken as the control, it could be assumed
that the absence of expression decrease in studied 20 miRNAs
in tumors was due to a decrease in their expression in the sur-
rounding tissues, which eliminated the difference in the quantity
of miRNAs in tumors and surrounding tissues. An additional
experiment, in which kidney tissue from healthy donors with
no history of cancer was taken as a control, showed decreased
expression of miR-125b, miR-124a, miR-127, miR-203, miR-34c-
3p, miR-9, miR-129, miR- 34b in histologically normal tissue of
patients with RCC. There was identified a group of miRNAs out
of studied 20 ones which may be involved in the progression of
RCC, they were at least miR-129, miR-375 and miR-9. Expression
characteristics of miRNAs require further study and may be used
as biomarkers.
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Background: Heparansulfate (HS) is a glycosaminoglycan pre-
sent on the cell surface and in the extracellular matrix, which
interacts with diverse signal molecules and is essential for many
physiological processes including embryonic development, cell
growth, inflammation, and blood coagulation. D-glucuronyl C5-
epimerase (GLCE) is a crucial enzyme in HS synthesis, converting
D-glucuronic acid (GlcA) to L-iduronic acid (IdoA) to increase HS
flexibility. Aberrant modification may result in wrong structure
of polysaccharide chains of HS and defects of microenvironment
associated with malignant transformation.We previously
experimentally identified the GLCE polymorphism Ile597Val. Its
localization close to the activity center of the enzyme and differ-
ent physical parameters of the involved amino acids suggest that
the polymorphism is functional. So, three different variants of
GLCE dimers with different enzymatic activity may exist in
heterozygous carriers. Bioinformatics’ search (PubMed resource)
revealed interracial variations in allele frequency distribution.
Unusual high frequency of allele G was shown for black
race (45%) compared with white race (17%). Taking into account
the increased resistance of negroid race to breast cancer, we
assume a potential involvement of the GLCE polymorphism in
breast cancer.
Aim: The estimation of effects of GLCE functional polymor-
phism A2017G (Ile597Val) on the gene expression levels in normal
and breast cancer cells and LOH in breast tumors.
Materials and methods: Breast cancer patients (n = 144.) had
histologically verified diagnoses. Blood and breast cancer tissue
samples as well as matched control tissues were collected from
each patient during surgery. Genomic DNAwas isolated by phenol
extraction. Total RNA was isolated by TRIZol, RNA quantity was
accessed by Qubit instrument with appropriate reagents and
cDNA was obtained using First Strand cDNA Synthesis kit. SNP
A2017G (rs3865014) was analyzed by Custom Real-Time SNPArray
and GLCE expression levels were determined using Taq-Man-
based Real-Time PCR (Applied Biosystems). Statistical analysis
was carried out using a Statistika 9.0 software.
Results: AA genotype carriers had a 2-fold increase in GLCE
mRNA levels in tumors compared with control surrounding
tissues (0.37 ± 0.77 versus 0.17 ± 0.16, respectively, p < 0.05). Oppo-
sitely, AG genotype carriers had a 1.5-fold decrease in GLCE mRNA
levels in tumors compared with control surrounding tissues
(0.39 ± 0.29 versus 0.58 ± 0.33, respectively, p < 0.05 ). However, in
any case,the GLCE expression in both normal tissues and breast
tumors was more active in AG genotype carriers than in AA
carriers. It is known that LOH is often associated with molecular
mechanisms of carcinogenesis, we studied this process for the
same patients. According our results, LOH was detected in about
10% of cases (5/52 patients), among which G was lost in 3 patients
and A was lost in 2 patients.
Conclusion: The obtained data show a possible association
between GLCE Ile597Val polymorphism and breast cancer,
although the nature of the association remains ambiguous.
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P142
Glioma-derived osteopontin and lactadherin shape tumor microen-
vironment and immune response in rat model of glioma
D. Pszczo´łkowska*, A. Ellert-Miklaszewska, A. Gieryng,
M. Kijewska, P. Wis´niewski, B. Kamin´ska. Nencki Institute of
Experimental Biology, Polish Academy of Sciences, Warsaw, Poland
⇑
Corresponding author.
Malignant gliomas are fast-growing, heterogeneous and inva-
sive brain tumors strongly infiltrated by non-tumor cells. Glioma
attracts variety of immune cells, in particular microglia/
macrophages and re-program these cells into immunosuppres-
sive, tumor-supporting cells. Factors responsible for
pro-invasive macrophage polarization and shaping tumor
microenvironment in tumor-supporting manner are poorly
known. We analyzed glioma secretome using proteomical
approach and identified lactadherin (Mfge8) and osteopontin
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(Spp1) in microglia-activating fractions. Both osteopontin and lac-
tadherin are avb3/avb5 integrin ligands able to interact with
receptors present on microglia and macrophages and thus could
be involved in pro-invasive polarization of microglia/
macrophages. Moreover, both Spp1 and Mfge8 are overexpressed
in glioma cells, but not in non-transformed astrocytes. C6 glioma
cells stably expressing shRNA specific to lactadherin (shMfge8),
osteopontin (shSpp1) and negative shRNA (shNeg) were
implanted into striatum of Wistar rats. There was no difference
in proliferation and viability of C6 glioma cells, cells stably
expressing shRNA specific to lactadherin, ostopontin and nega-
tive shRNA in vitro, that demonstrates the negligible effect of
autocrine production of both protein on tumor cell growth.
Knockdown of Spp1 and Mfge8 resulted in significant reduction
of tumor volume in rat model of glioma. Immunochemical anal-
ysis of brain sections revealed similar numbers of infiltrating
microglia/macrophages (Iba1 staining), but the reduced number
of ameboid, arginase 1 expressing cells in Mfge8 – depleted tumor.
Treatment of endothelial cells with rhMFGE8 revealed significant
effect of that protein on angiogenesis in vitro, however
lactadherin-depleted tumors do not exhibit reduced blood vessel
density in rat glioma model. FACS analysis showed that silencing
of Spp1 does not affect total number of CD11b-positive cells, but
strongly modulates microenvironment by leading to significant
changes in percentage of Tc and Treg cells infiltrating tumor-
bearing hemisphere. Our results suggest that glioma-derived
integrin ligands are important factor in polarization of glioma
infiltrating microglia/macrophages into the pro-invasive pheno-
type and its targeting could be a new therapeutic strategy.
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It’s well documented that cytokines in patients with breast
cancer are indicators of survival, assessing the risk of recurrence
and mortality. However, the obtained data about serum levels of
cytokines are contradictory. The problem of participation of
cytokines in the growth and spread of tumors requires further
study.
The purpose was the determination of serum level of cytokine
in experimental model of breast cancer in Wistar rat. Material
and methods: Breast cancer was induced by intramammalirian
injection of N-methyl-N-nitrosourea. Some of the rats were sub-
jected to only surgery or only polychemotherapy (cyclophos-
phamide, methotrexate, 5-fluorouracil).Serum levels of
cytokines: Bio-Plex Pro Rat Cytokines 24-Plex Assay (Bio-Rad,
USA) were used.
Results: It was found that the serum levels of IL-1b, IL-2, IL-4,
IL-5, IL-6, IL-7, IL-12, IL-13, IL-17A, IFN -c, MIP-1a, MIP-3a, RANTES,
TNF-a in rats with experimental breast cancer were significantly
higher compared with intact rats. We obtained that pro-
inflammatory cytokines are associated with progression of breast
cancer in rats. The serum levels of IL-1a, IL-2, IL-4, IL-12, IL-18,
G-CSF, GM-CSF, GRO/KC, IFN-c, MIP-1a, RANTES in rats after
surgical treatment were significantly higher compared to those
in rats without surgical treatment. It was also observed that in
rats after surgical treatment,the serum levels of IL-1a, IL-2, IL-4,
IL-12, IL-18, G-CSF, GM-CSF, GRO/KC, IFN-c, MIP-1a, RANTES were
decreased. We suppose that these data may indicate that tumor
cells can also produce cytokines. Moreover, we obtained that in
intact rats, serum levels of IL-1a, IL-18, EPO, G-CSF, GRO/KC,
MIP-1a were higher compared to those in rats with breast
cancer treated with surgery. However, the serum levels of IL-6
and IL-1b (markers of pro- inflammation and tumor metastasis)
were higher in surgically treated rats compared to those in intact
rats. It has been proved that the removal of primary tumors
(without regional lymph node removal and subsequent poly-
chemotherapy) can lead to accelerated growth of metastases. It
was found that the polychemotherapy resulted in a significant
decrease in the serum levels of IL-1a, IL-1b, IL-2, IL-4, IL-5, IL-6,
IL-7, IL-10, IL-12, IL-13, IL-17A, IL-18. Polychemotherapy also leads
to suppression in serum levels RANTES, VEGF, MCP-1. We found
that the serum levels of IL-2, IL-5, IL-7, IL-13, IL-17A, IL-18,
G-CSF were significantly higher in rats after combination of
surgery and polychemotherapy.
Conclusion: The serum level of cytokines in rats with experi-
mental breast cancer depends on the type of treatment.
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Colon adenocarcinoma is one of the most wide spreading
malignant tumors in the world, mortality of which remains high.
Estimation of cancer on late stages, absence of prognostic and
predictive factors, poor understanding of progression mechanism
may lead to elevation of mortality.
The aim of investigation was to identify morphologic prognos-
tic factors and their combination for colon adenocarcinoma.
For this purpose 776 patients with colon adenocarcinoma with
the median age 57.6 years were selected. Receptors for chemokine
(CCR10, CXCR4), stem cell marker (ALDH1), ki-67, MSH2, MSH6,
MLH1, PMS2 were investigated by immunohistochemistry (IHC).
Results of IHC were compared with clinical data. Analysis of 217
colon adenocarcinomas by Ki-67 showed that 86% of cases had
high proliferative level (Ki-67>30%), among them 39% of cases
had very high level of Ki-67 (>70%). We also analyzed proliferation
of stem cells using double IHC stain for ALDH1 and Ki-67. It was
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